Skip to main content
NTUS logo

Natus Medical Incorporated (NTUS) Stock Analysis

DELISTED

What happened to Natus Medical Incorporated (NTUS) stock?

Natus Medical Incorporated (NTUS) no longer trades on public markets. The figures below are historical and are not a current quote.

Status:
Delisted — no longer trades
P/E Ratio: 84.51| Vol: 132.7K| 52-wk range: $32.84 – $33.07

P/E 84.51 means the share price is 84.51 times one year of earnings per share.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Natus Medical Incorporated (NTUS). Natus Medical Incorporated provides medical device solutions for the diagnosis and treatment of central nervous and sensory system disorders.

Last analyzed: May 10, 2026
Natus Medical Incorporated provides medical device solutions for the diagnosis and treatment of central nervous and sensory system disorders. The company offers products and technologies used for screening, detection, treatment, and monitoring of medical ailments in newborn care, hearing impairment, neurological treatments, and sleep disorders.

Natus Medical Incorporated (NTUS) Healthcare & Pipeline Overview

Employees1,400
Model self-rating on this text: 66% (not a measure of the evidence) Updated: May 10, 2026

More about this archive record

Can I still buy NTUS shares?

No. NTUS stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for NTUS elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before NTUS stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Natus Medical Incorporated. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: .

Data provided for informational purposes only.